Corporate Headquarters
C/ Ferraz 78- 2º Izqda
28008 Madrid
40.425846x-3.717027:16
Latest News
|
Leadartis announces the publication "An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad anti-tumor activity in humanized murine cancer models without toxicity” in Clinical Cancer Research
02-04-2021
|
Leadartis reaches a major milestone with the demonstration of absence of toxicity of its drug candidate in preclinical models
13-01-2021
Leadartis reaches a major milestone with the demonstration of... |
Leadartis featured in EXPANSION as a ‘Start up’ that leads the fight against cancer
10-11-2020
... |
